有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(4-chlorophenyl)-5-[(1R)-1-(4-fluorophenyl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12ClFN2OS |
|
—— | 2-(4-chlorophenyl)-5-[(1S)-1-(4-fluorophenyl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12ClFN2OS |
|
—— | N-[2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]-1-methylpyrrole-2-carboxamide | —— | C16H13ClN4O3S |
|
—— | 2-(4-Chlorophenyl)-5-[[2-(4-methylphenyl)-1,3-thiazol-4-yl]methylsulfanyl]-1,3,4-oxadiazole | —— | C19H14ClN3OS2 |
|
—— | ethyl (2R)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-phenylacetate | —— | C18H15ClN2O3S |
|
—— | 2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1R)-1-(3,4-dimethylphenyl)ethyl]acetamide | —— | C20H20ClN3O2S |
|
—— | 2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N,N-bis(2-cyanoethyl)acetamide | —— | C16H14ClN5O2S |
|
—— | 2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(4-fluorophenyl)methyl]acetamide | —— | C17H13ClFN3O2S |
|
—— | 3-[(1R)-1-(2-chlorophenyl)ethyl]sulfanyl-4-cyclohexyl-5-(thiophen-2-ylmethyl)-1,2,4-triazole | —— | C21H24ClN3S2 |
|
—— | 3-[(1S)-1-(2-chlorophenyl)ethyl]sulfanyl-4-cyclohexyl-5-(thiophen-2-ylmethyl)-1,2,4-triazole | —— | C21H24ClN3S2 |
|
—— | 3-[[4-Cyclohexyl-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]propanenitrile | —— | C16H20N4S2 |
|
—— | 4-propyl-3-[(1R)-2,2,2-trifluoro-1-[(2S)-oxolan-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C11H16F3N3O2S |
|
—— | 4-propyl-3-[(1S)-2,2,2-trifluoro-1-[(2S)-oxolan-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C11H16F3N3O2S |
|
—— | (3S)-3-[[4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C13H13F3N4O2S |
|
—— | (3R)-1-(2,2,2-trifluoroethyl)-3-[1-(2,2,2-trifluoroethyl)tetrazol-5-yl]sulfanylpyrrolidin-2-one | —— | C9H9F6N5OS |
|
—— | (3S)-3-(5-methylpyridin-2-yl)sulfanyl-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C12H13F3N2OS |
|
—— | (3R)-3-[[4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C13H13F3N4O2S |
|
—— | (3S)-1-(2,2,2-trifluoroethyl)-3-[1-(2,2,2-trifluoroethyl)tetrazol-5-yl]sulfanylpyrrolidin-2-one | —— | C9H9F6N5OS |
|
—— | (3R)-3-[[5-(prop-2-enylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C11H13F3N4OS2 |
|
—— | 4-propyl-3-[(1S)-2,2,2-trifluoro-1-[(2R)-oxolan-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C11H16F3N3O2S |
|
—— | (3S)-3-[[5-(prop-2-enylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C11H13F3N4OS2 |
|
—— | 4-propyl-3-[(1R)-2,2,2-trifluoro-1-[(2R)-oxolan-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C11H16F3N3O2S |
|
—— | [2-Oxo-2-(2-phenylsulfanylanilino)ethyl] 2-(3,4-dimethylphenyl)acetate | —— | C24H23NO3S |
|
—— | 2-[[4-methyl-5-[(3S)-piperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]-4-(trifluoromethyl)pyrimidine | —— | C13H15F3N6S |
|
—— | 1-[2-[(2S,5R)-2,5-dimethylpyrrolidin-1-yl]ethyl]-4-(2-phenylsulfanylethyl)piperazine | —— | C20H33N3S |
|
—— | [(2S)-1-(2-phenylsulfanylethyl)pyrrolidin-2-yl]methanesulfonamide | —— | C13H20N2O2S2 |
|
—— | 1-[2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]ethyl]-4-(2-phenylsulfanylethyl)piperazine | —— | C20H33N3S |
|
—— | (3R)-3-(5-methylpyridin-2-yl)sulfanyl-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C12H13F3N2OS |
|
—— | N-[[(3S)-1-(2-phenylsulfanylethyl)piperidin-3-yl]methyl]methanesulfonamide | —— | C15H24N2O2S2 |
|
—— | (2S)-2-methyl-4-[1-(2-phenylsulfanylethyl)piperidin-4-yl]morpholine | —— | C18H28N2OS |
|
—— | [(3S)-1-(2-phenylsulfanylethyl)piperidin-3-yl]methanesulfonamide | —— | C14H22N2O2S2 |
|
—— | N-[[(2R)-4-[3-(2-chlorophenyl)sulfanylpropyl]morpholin-2-yl]methyl]acetamide | —— | C16H23ClN2O2S |
|
—— | [(3R)-1-(2-phenylsulfanylethyl)piperidin-3-yl]methanesulfonamide | —— | C14H22N2O2S2 |
|
—— | N-[[(3R)-1-(2-phenylsulfanylethyl)piperidin-3-yl]methyl]methanesulfonamide | —— | C15H24N2O2S2 |
|
—— | [(2R)-1-(2-phenylsulfanylethyl)pyrrolidin-2-yl]methanesulfonamide | —— | C13H20N2O2S2 |
|
—— | (2R)-2-methyl-4-[1-(2-phenylsulfanylethyl)piperidin-4-yl]morpholine | —— | C18H28N2OS |
|
—— | N-[[(2S)-4-[3-(2-chlorophenyl)sulfanylpropyl]morpholin-2-yl]methyl]acetamide | —— | C16H23ClN2O2S |
|
—— | 2-[[4-methyl-5-[(3R)-piperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]-4-(trifluoromethyl)pyrimidine | —— | C13H15F3N6S |
|
—— | ethyl 2-[2-[(1S)-1-pyridin-4-ylethyl]sulfanyl-1,3-thiazol-4-yl]acetate | —— | C14H16N2O2S2 |
|
—— | ethyl 2-[2-[(1R)-1-pyridin-4-ylethyl]sulfanyl-1,3-thiazol-4-yl]acetate | —— | C14H16N2O2S2 |
|
—— | methyl (2S)-2-[(5-ethyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-2-(4-fluorophenyl)acetate | —— | C14H16FN3O2S |
|
—— | methyl (2S)-2-(4-fluorophenyl)-2-[[4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C16H14FN3O3S |
|
—— | methyl (2R)-2-(4-fluorophenyl)-2-[[4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C16H14FN3O3S |
|
—— | methyl (2R)-2-[(5-ethyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-2-(4-fluorophenyl)acetate | —— | C14H16FN3O2S |
|
—— | 2-(3-chlorophenyl)-5-[(1R)-1-(1,3-thiazol-2-ylsulfanyl)ethyl]-1,3,4-oxadiazole | —— | C13H10ClN3OS2 |
|
—— | 2-(3-chlorophenyl)-5-[(1S)-1-(1,3-thiazol-2-ylsulfanyl)ethyl]-1,3,4-oxadiazole | —— | C13H10ClN3OS2 |
|
—— | N-[(2R)-2-cyanopropyl]-1-phenylsulfanylcyclopentane-1-carboxamide | —— | C16H20N2OS |
|
—— | [2-Oxo-2-(propylamino)ethyl] 2-[(4-benzyl-5-cyclopropyl-1,2,4-triazol-3-yl)sulfanyl]acetate | —— | C19H24N4O3S |
|
—— | (2R)-3-methyl-N-(pyridin-3-ylmethyl)-2-thiophen-2-ylsulfanylbutanamide | —— | C15H18N2OS2 |
|
—— | N-[(2S)-2-cyanopropyl]-1-phenylsulfanylcyclopentane-1-carboxamide | —— | C16H20N2OS |
|